These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 17550302)

  • 1. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
    Bero L; Oostvogel F; Bacchetti P; Lee K
    PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with results and conclusions of trials of thiazolidinediones.
    Rattinger G; Bero L
    PLoS One; 2009 Jun; 4(6):e5826. PubMed ID: 19503811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry sponsorship and research outcome.
    Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
    Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
    JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.
    Rahimi K; Emberson J; McGale P; Majoni W; Merhi A; Asselbergs FW; Krane V; Macfarlane PW;
    BMJ; 2011 Mar; 342():d1250. PubMed ID: 21411487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trials in HEPATOLOGY: predictors of quality.
    Kjaergard LL; Nikolova D; Gluud C
    Hepatology; 1999 Nov; 30(5):1134-8. PubMed ID: 10534332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry sponsorship and research outcome.
    Lundh A; Lexchin J; Mintzes B; Schroll JB; Bero L
    Cochrane Database Syst Rev; 2017 Feb; 2(2):MR000033. PubMed ID: 28207928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias in clinical intervention research.
    Gluud LL
    Am J Epidemiol; 2006 Mar; 163(6):493-501. PubMed ID: 16443796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trials in otolaryngology journals.
    Yao F; Singer M; Rosenfeld RM
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):539-44. PubMed ID: 17903567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
    Rasmussen N; Lee K; Bero L
    Trials; 2009 Dec; 10():116. PubMed ID: 20015404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial relationships in economic analyses of targeted therapies in oncology.
    Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
    J Clin Oncol; 2012 Apr; 30(12):1316-20. PubMed ID: 22430267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of methodological quality and outcome measures of acute stroke randomized controlled trials in China in recent 15 years.
    He S; Wu S; Zeng Q; Zhang S; Lin S; Zhang C; Cui X; Liu M
    J Evid Based Med; 2012 Aug; 5(3):174-82. PubMed ID: 23672224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.